Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies

Anti-DLL3 antibodies and drug conjugates for use in melanoma

Anti-Jagged1 antibodies and methods of use

Dosage and administration of non-fucosylated anti-CD40 antibodies

Methods of inducing or enhancing an immune response in a subject having cancer by administering GITR antibodies

Targeted binding agents against B7-H1

CTLA4 binders

PD1/CTLA4 binders

CD3-binding molecules capable of binding to human and non-human CD3

PD1 and/or LAG3 binders

Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

KV1.3 binding immunoglobulins

Antibodies to IL-15

VACCINES AND MONOCLONAL ANTIBODIES TARGETING TRUNCATED VARIANTS OF OSTEOPONTIN AND USES THEREOF

ANTAGONISTS OF BMP9, BMP10, ALK1 AND OTHER ALK1 LIGANDS, AND USES THEREOF

Methods of diagnosing diseases caused by or associated with neurofibrillary tangles by phosphospecific antibodies recognising Tau

Compositions and methods for treating and preventing influenza

Fibronectin binding domains with reduced immunogenicity

Epitope tag and method for detection and/or purification of tagged polypeptides

Antibody, epitope tag and method for detection, capture and/or purification of tagged polypeptides

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

Animal models and therapeutic molecules

MULTISPECIFIC ANTIBODIES

Antibody constructs for CD70 and CD3

Human antibodies to the glucagon receptor and methods of use thereof for lowering blood glucose or ketone levels

Antibodies directed against CD127

Anti-Axl antibodies

Use of Anti-MCAM Antibodies for Treatment or Prophylaxis of Giant Cell Arteritis, Polymyalgia Rheumatica or Takayasus Arteritis

Method of reducing pruritus using IL-31 monoclonal antibodies

NOVEL HUMAN CONTROL ANTIBODIES AND USES THEREFOR

Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active Ingredient

Humanized anti-Tau(pS422) antibodies and methods of use

Antibody molecule-drug conjugates and uses thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

IL-6-binding polypeptide complex

Methods for treating cancer using nanoparticle complexes of paclitaxel, rituximab, and albumin

Nanoparticle complexes of rituximab, albumin and pacltaxel

Nanoparticle complexes of paclitaxel, cetuximab, and albumin, and methods of making the same

Methods for treating cancer using nanoparticle complexes of paclitaxel, cetuximab, and albumin

Nanoparticle complexes of paclitaxel, cetuximab, and albumin

Methods of treating cancer with antibody-albumin nanoparticle complexes comprising albumin, trastuzumab, and paclitaxel

Methods for treating CD52-expressing cancers using compositions comprising nanoparticle complexes of paclitaxel, alemtuzumab, and albumin

Screening of protein candidates

Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal antibodies

Antibodies against HPA-1a

ANTI-IL1RAP ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND IL1RAP AND CD3, AND USES THEREOF

Anti-CD324 monoclonal antibodies and uses thereof

Antibody-drug conjugates, their preparation and their therapeutic use

Anti-IL-6 Receptor Antibody

VEGFR2/Ang2 Compounds

Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses

Anti-transthyretin antibodies

Antibodies recognizing medin

High affinity antibodies that neutralize enterotoxin B

Single domain antibodies directed against human immunodeficiency virus

Antibody neutralizing human respiratory syncytial virus

Single domain antibodies directed against ebola virus VP24

Method for neutralizing hepatitis C virus, fully human monoclonal antibody against hepatitis C virus (variants), composition of fully human monoclonal antibodies against hepatitis C virus and hybrid mouse/human producer cell line of fully human monoclonal antibodies against hepatitis C virus (variants)

Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cells

Combination therapies targeting tumor-associated stroma or tumor cells and microtubules

Methods of aiding in the diagnosis of diseases using anti-IL-6 antibodies

Methods and compositions for increasing α-L-iduronidase activity in the CNS

Humanized antibodies that bind LGR5

Bispecific antibodies specific for OX40

Antibodies against human CSF-1R and uses thereof

Bispecific antibodies specific for PD1 and TIM3

Anti-IL-2 antibodies and compositions and uses thereof

MONOCLONAL ANTIBODIES AGAINST THE RGM A PROTEIN FOR USE IN THE TREATMENT OF RETINAL NERVE FIBER LAYER DEGENERATION

VEGF-A-BINDING PROTEINS AND HER2-BINDING PROTEINS WITH ENHANCED STABILITY AGAINST AGGREGATION

Monoclonal antibodies against orthopoxviruses

Stable antibody-drug conjugate, preparation method therefor, and use thereof

Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase

Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents

Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells

Method for preparing antibody through regulation of sugar content of antibody

STABILIZED SINGLE DOMAIN ANTIBODIES

Anti-chondroitin-sulfate-E antibody

Antibodies against immunogenic glycopeptides, compositions comprising the same and use thereof

Combination therapies with anti-CD38 antibodies

MEDICAMENTS, USES AND METHODS

Antagonists for abdominal vasopressin V2 receptor and uses thereof

Anti-Axl antibodies

Dual receptor antagonistic antigen-binding proteins and uses thereof

Anti-PD-L1 antibodies, compositions and articles of manufacture

Provasopressin antagonists and uses thereof

TNF alpha antibody or fragment thereof and methods of use

ANG2-BINDING MOLECULES

Antibodies to HGF and compositions containing

Heavy chain only antibodies to ANG-2

Antibodies to tau and methods of treatment therewith

Therapeutic use of specific ligand in MSRV associated diseases

Constructs having a SIRP-α domain or variant thereof

ANTIBODY DRUG CONJUGATES

Humanized anti-tau(pS422) antibody brain shuttles and use thereof

Animal Models and Therapeutic Molecules

Animal models and therapeutic molecules

Animal Models and Therapeutic Molecules

Pharmaceutical compositions comprising an antibody which binds the human anti-Müllerian hormone receptor type II

Antigen-binding proteins that activate the leptin receptor

Nucleic acids encoding chemokine receptor binding polypeptides

Anti-LAG3 antibodies and uses thereof

Use of Anti-MCAM Antibodies for Treatment or Prophylaxis of Giant Cell Arteritis, Polymyalgia Rheumatica or Takayasus Arteritis

Human-mouse chimeric anti-CD147 antibody with non-fucosylated glycosylation

HUMAN ANTI IL-6 ANTIBODIES WITH EXTENDED IN VIVO HALF-LIFE AND THEIR USE IN TREATMENT OF ONCOLOGY, AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES

Nucleic Acid Encoding Anti-IL13 Human Antibodies

Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature

Bispecific antibody fragments for neurological disease proteins and methods of use

Carbohydrate antibodies, pharmaceutical compositions and uses thereof

Carrier-antibody compositions and methods of making and using the same

Animal Models and Therapeutic Molecules

Animal models and therapeutic molecules

USE OF ANTIBODY CONJUGATES

Anti-PCSK9 antibodies

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

Anti human Notch4 antibody

HUMAN ANTIBODIES TO HUMAN TNF-LIKE LIGAND 1A (TL1A)

Nucleic acids encoding activatable antibodies that bind epidermal growth factor receptor

Human antibodies to GFR alpha3 and methods of reducing pain associated with GFR alpha3-related diseases

Antibodies specifically binding to HER3

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOR NECROSIS FACTOR-ALPHA AND USES THEREFOR

ANTIBODY VARIANTS

Optimized variants of anti-VEGF antibodies and methods of treatment thereof by reducing or inhibiting angiogenesis

Anti-GP73 monoclonal antibodies and methods of obtaining the same

Single domain binding molecule

Antibodies that neutralize botulinum neurotoxins

Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathways

ANIMAL MODELS AND THERAPEUTIC MOLECULES

TREATMENT OF NEUROTRAUMA USING ANTIBODIES TO LYSOPHOSPHATIDIC ACID

Compositions for inhibiting MASP-2 dependent complement activation

Immunoconjugates

Agonistic antibodies specifically binding CD40 and methods of use

Anti-TIE2 antibodies and uses thereof

Methods of treating cardiovascular disease with an ASGR inhibitor

PD-1 binding proteins and methods of use thereof

CD33 binding agents

Anti-TIM-3 antibody

Monoclonal antibodies to programmed death 1 (PD-1)

Compositions and methods related to anti-CD19 antibody drug conjugates

Anti-tigit antibodies and methods of use

Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same

Polyomavirus neutralizing antibodies

Multimeric Fc proteins

Drug conjugates for delivering compounds to senescent cells

MDR specific antibody

Heterodimeric antibodies to CD3 X CD123

ANIMAL MODELS AND THERAPEUTIC MOLECULES - Track 1

ANTI-C-MET TANDEM FC BISPECIFIC ANTIBODIES

Heterodimeric antibodies to CD3 X CD20

Modulators and methods of use

IMMUNOCONJUGATES TARGETING CD138 AND USES THEREOF

Human monoclonal antibody human CD134 (OX40) and methods of making and using same

ANTAGONIST ANTI-CD40 MONOCLONAL ANTIBODIES AND METHODS FOR THEIR USE

Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Antibody-fynomer conjugates

Anti-PD-1 antibodies and methods of use thereof

Anti-PVRIG antibodies and methods of use

MULTIMERIC FC PROTEINS

Mesothelin-targeted chimeric antigen receptors and uses thereof

Bispecific format suitable for use in high-through-put screening

Anti-IL-17 antibodies

Antibodies that specifically bind to TL1A

Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof

Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV

TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS

ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE AND METHODS USING SAME

Composition that relieves heartburn, GERD and hangovers

Humanized monoclonal antibodies and methods of use

Tissue factor pathway inhibitor antibodies and uses thereof

ANTIBODIES AGAINST THE ECTODOMAIN OF ERBB3 AND USES THEREOF

GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapy

Compositions and methods for the diagnosis and treatment of tumor

Polynucleotides encoding anti-KIT antibodies

Anti-C5a receptor antibodies

Bispecific tetravalent antibodies and methods of making and using thereof

Anti-B7-H3 antibodies and diagnostic uses thereof

NOVEL MULTISPECIFIC MOLECULES AND NOVEL TREATMENT METHODS BASED ON SUCH MULTISPECIFIC MOLECULES

Anti-SIRP-alpha antibodies and bispecific macrophage enhancing antibodies

METHODS FOR TREATING VISCERAL PAIN BY ADMINISTERING ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE

Method of treating auto-inflammatory syndromes with IL-1beta antibodies related to canakinumab

Anti-activin A antibodies and uses thereof

COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION

ANTI-VEGF ANTIBODIES

CGRP ANTIBODIES

METHODS OF TREATING INFLAMMATORY PAIN

Humanized antibodies

Anti-EGFR antibodies and antibody drug conjugates

Carrier-antibody compositions and methods of making and using the same

ANIMAL MODELS AND THERAPEUTIC MOLECULES

Anti-IL-17A Antibodies

Thrombin-binding antibody molecules and uses thereof

Anti-survivin antibodies for cancer therapy

Esophageal cancer marker and use thereof

Prion protein antibodies for the treatment of Alzheimer's disease

COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERY OF IGG-DECOY RECEPTOR FUSION PROTEINS

ST2L antagonists and methods of use

Monoclonal antibodies against HER2 epitope and methods of use thereof

Humanized anti-HLA-DR antibodies

Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules

Antibodies to TGF-beta

ANTI-NGF ANTIBODIES FOR THE TREATMENT OF VARIOUS DISORDERS

Humanized pertussis antibodies and uses thereof

Monoclonal antibodies that neutralize a norovirus

Heterodimeric proteins and methods for producing and purifying them

COMPOSITIONS AND METHODS FOR SIMULTANEOUS BIVALENT AND MONOVALENT CO-ENGAGEMENT OF ANTIGENS

Nucleic acid molecules encoding for BACE1 antibodies

METHOD OF DETECTING OCULAR DISEASES AND PATHOLOGIC CONDITIONS AND TREATMENT OF SAME

Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist

Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof

ANTI-CD40 ANTIBODIES

Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and stroke

Antibodies that bind EGFR and ErbB3

PD-L1 antibodies

Anti-CD79B antibodies and immunoconjugates and methods of use

HUMAN ANTIBODIES THAT BIND CD22 AND USES THEREOF

Engineered antibody FC variants

APLNR modulators and uses thereof

IL-1 BINDING PROTEINS

Humanized anti-tau antibodies

Anti-transthyretin antibodies

Fusion protein for treating rejection reaction in transplantation

Formulation of human antibodies for treating TNF-alpha associated disorders

Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies

Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies

METHOD OF DETECTING OCULAR DISEASES AND PATHOLOGIC CONDITIONS AND TREATMENT OF SAME

Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof

Anti-BCMA antibodies and uses thereof

Dual specific immunotoxin for brain tumor therapy

Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies

Anti-vista antibodies and fragments

Immunostimulatory anti-CEACAM1 antibody

Antibodies to MAdCAM

Therapeutic drug for malignant tumors

Human anti-IFN-α antibodies

Nucleic acid molecules encoding monoclonal antibodies specific for IL-22

Anti-NGF antibodies that selectively inhibit the association of NGF with TRKA without affecting the association of NGF with P75

Clostridium difficile antibodies

USE OF ANTI-CCR5 ANTIBODIES IN GRAFT VERSUS HOST DISEASE

Humanized antibodies against CEACAM1

Endoglin antibodies

Cytotoxic benzodiazepine derivatives

Humanized anti-CXCR5 antibodies, derivatives thereof and their uses

Humanized monoclonal antibodies and methods of use

PD-1 antibodies

Anti-PD1 antibodies, activatable anti-PD1 antibodies, and methods of use thereof

Method of treating atopic dermatitis with IL-31 monoclonal antibodies

Anti-IL-23 antibody compositions

Methods of treating SLE with anti-OX40L antibodies

Heavy chain only antibodies to PDGF

FC-REGION VARIANTS WITH IMPROVED PROTEIN A-BINDING

Treatment of central nervous system disorders by intranasal administration of immunoglobulin G

METHODS OF TREATING CHRONIC PAIN

Phage-displayed antibody libraries and uses thereof

Engineering of immunoglobulin domains

Methods, compositions, and kits for detection of aspergillosis

Antibody constructs for FLT3 and CD3

Antibodies for the prevention or the treatment of bleeding episodes

Mutated antibody of fully humanized HER2 antibody, and encoding gene and use thereof

Antibody that binds ErbB-2 and ErbB-3

Anti-MCAM antibodies and associated methods of use

Anti-CD154 antibodies and methods of using them

Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia

Method of treating cancer using immune checkpoint inhibitor

Antibody constructs for DLL3 and CD3

Antibody therapeutics that bind CD147

Anti-ANGPTL8 antibodies and uses thereof

Polynucleotides encoding VNAR anti-cytokine domains

FC-REGION VARIANTS WITH MODIFIED FCRN-BINDING PROPERTIES

COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS

Antibody capable of binding to influenza virus

Fibronectin binding domains with reduced immunogenicity

Antibody drug conjugates

Antibodies, antibody drug conjugates and methods of use

DIAGNOSIS OF CHRONIC KIDNEY DISEASE BY QUANTITATIVE ANALYSIS OF POST-TRANSLATIONAL MODIFICATIONS OF PLASMA PROTEINS

Methods of selectively treating asthma using IL-13 antagonists

Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl tRNA synthetases

Bispecific HER2 antibodies and methods of use

Antibodies, pharmaceutical compositions and uses thereof

Humanized and chimeric monoclonal antibodies to CD99

Fn14 Binding Proteins and Uses Thereof

Antibodies against human CSF-1R and uses thereof

Anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies and uses thereof

Anti-CD123 antibodies and conjugates and derivatives thereof

PDGF receptor beta binding polypeptides

Antigen binding constructs to CD8

Anti-PVRIG antibodies and methods of use

Antibody constructs for MSLN and CD3

Anti-EPHRINB2 antibodies and methods using same

METHODS FOR TREATING HEPCIDIN-MEDIATED DISORDERS

IMMUNOGLOBULINS

Human Antibodies that Bind Human TNF-Alpha and Methods of Preparing the Same

Antigen Binding Constructs

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

HUMAN ANTIBODIES TO HUMAN DELTA LIKE LIGAND 4

Human monoclonal antibody with specificity for dengue virus serotype 1 E protein and uses thereof

Human antibodies to respiratory syncytial virus F protein and methods of use thereof

Pincers comprising antibody and aptamer conjugated via a linker which binds to the same target material and use thereof

Anti-antibodies and methods of use